Assemblywoman Malliotakis presents a Proclamation announcing April as “Parkinson’s Disease Awareness Month” to Leslie...see more A. Chambers (left), President & CEO of APDA, and Fred Greene (right), Chairman of the APDA Board of Directors. Today Assemblywoman Nicole Malliotakis (R,C,I-East Shore) joined the American Parkinson Disease Association (APDA) at their national headquarters, […]

Read More

APDA Partners with BioMech to Raise Funds and Get Golfers With Parkinson’s Disease Back into the Swing People with...see more Parkinson’s can enhance the joy of golf, thanks to a cutting-edge and innovative golf club! The symptoms of Parkinson’s disease can make playing golf incredibly challenging, and in some cases, impossible. BioMech Golf’s AccuLock ACE putter […]

Read More

(New York, NY, June 3, 2015) – The...see more American Parkinson Disease Association (APDA) announces it has joined The Parkinson’s Action Network (PAN) Unified Partners Program.American Parkinson Disease Association Is Proud To Join Parkinson’s Action Network’s Unified Partners Program New program allows Parkinson’s-related organizations to […]

Read More

American Parkinson Disease Association official charity of Rite Aid Cleveland Marathon 2015 The Rite Aid Cleveland Marathon named the...see more American Parkinson Disease Association as the official charity of all walking divisions in 2015. The 38th annual event took place May 16 and 17, offering a walking division for the full marathon, half marathon, 10K and […]

Read More

The American Parkinson Disease Association (APDA), has awarded more than $1.1 million in seven research grants, four post-graduate fellowships,...see more and funding for centers for advanced research at eight major academic and medical centers across the country. To date, the country’s largest grassroots organization serving 1.5 million Americans with the disease has contributed more than $80 […]

Read More

2013-2014 Grant Progress Updates September 2014 Research Grants Ming Guo, MD, PhD UCLA David Geffen School of Medicine Study...see more Title: Identification and Characterization of a Suppressor of the PINK1/Parkin Pathway in Drosophila and Mammalian Cells Mutations in PINK1 and parkin lead to autosomal recessive forms of Parkinson’s disease (PD)/Parkinsonism. We and others have previously found […]

Read More

By: Alice Lazzarini, PhD On July 31st, the Austrian biotech company,...see more AFFiRiS AG announced the results of an early-stage trial of a vaccine intended to treat Parkinson’s disease. This is the first such study in Parkinson’s, although there has been work with similar strategies in Alzheimer disease. […]

Read More

Rytary A New Long Acting Carbidopa/Levodopa Formulation* Michael Rezak, MD, PhD Rytary™ (formerly known as IPX066), although not yet...see more released, has been shown to be effective in treating both early and later stage Parkinson’s disease symptoms. It is a unique formulation of carbidopa/levodopa, which provides longer and more stable duration of action compared to immediate […]

Read More

Detecting Parkinson’s Disease Early The genetic revolution of the 1990s has spurred the identification of seven disease-causing genes and...see more many additional genes that constitute risk factors for Parkinson’s. Deciphering the function of these genes has facilitated our capacity to understand pathways involved in the disease process. Everyday there are breakthrough publications featured on Medical News […]

Read More

Airborne Ranger-Turned-Writer Takes On a New Battle New York, New York – David Slone, a Rhode Island-based author, is...see more donating all net proceeds from the sale of his books in October and November to the American Parkinson Disease Association. David is the author of Rose Beach, set in the Plum Beach neighborhood of Saunderstown, Rhode […]

Read More